After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of ...

Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.43 in the first ...

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences business.

Becton Dickinson (NYSE:BDX) stock was down 3% in morning trading Thursday, the day after the company released its fiscal Q1 earnings report and confirmed it was splitting the company into two separate ...

Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.

The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...

Consensus is $14.35. Sees FY25 revenue $21.7B-$21.9B vs. previous view $21.9B-$22.1B, consensus $21.93B.Maximize Your Portfolio with Data ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

HDR, Flad Architects, Gensler, HOK, DGA, and Payette top Building Design+Construction's ranking of the nation's largest ...